Analyst Ratings for Dyne Therapeutics (DYN)
DYN Rating Summary
DYN Price Target Summary
- Highest: $50.00 (Jefferies)
- Lowest: $10.00 (JPMorgan)
- Average: $33.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.93 (+138.1%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$33.93 (+138.1%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2026 | JPMorgan | Tessa Romero | Downgrade | Underweight (Neutral) |
10.00 (N/A) |
24.28 (14.25) |
-41.31% | Details |
| 7/23/2026 | Cantor Fitzgerald » Updated 10/8/2026 |
Eric Schmidt | New Coverage | Overweight (N/A) |
N/A (N/A) |
23.21 (14.25) |
-38.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
